UNLABELLED: Liver transplant tissues offer the unique opportunity to model the longitudinal protein abundance changes occurring during hepatitis C virus (HCV)-associated liver disease progression in vivo. In this study, our goal was to identify molecular signatures, and potential key regulatory proteins, representative of the processes influencing early progression to fibrosis. We performed global protein profiling analyses on 24 liver biopsy specimens obtained from 15 HCV(+) liver transplant recipients at 6 and/or 12 months posttransplantation. Differentially regulated proteins associated with early progression to fibrosis were identified by analysis of the area under the receiver operating characteristic curve. Analysis of serum metabolites was performed on samples obtained from an independent cohort of 60 HCV(+) liver transplant patients. Computational modeling approaches were applied to identify potential key regulatory proteins of liver fibrogenesis. Among 4,324 proteins identified, 250 exhibited significant differential regulation in patients with rapidly progressive fibrosis. Patients with rapid fibrosis progression exhibited enrichment in differentially regulated proteins associated with various immune, hepatoprotective, and fibrogenic processes. The observed increase in proinflammatory activity and impairment in antioxidant defenses suggests that patients who develop significant liver injury experience elevated oxidative stresses. This was supported by an independent study demonstrating the altered abundance of oxidative stress-associated serum metabolites in patients who develop severe liver injury. Computational modeling approaches further highlight a potentially important link between HCV-associated oxidative stress and epigenetic regulatory mechanisms impacting on liver fibrogenesis. CONCLUSION: Our proteome and metabolome analyses provide new insights into the role for increased oxidative stress in the rapid fibrosis progression observed in HCV(+) liver transplant recipients. These findings may prove useful in prognostic applications for predicting early progression to fibrosis.
UNLABELLED: Liver transplant tissues offer the unique opportunity to model the longitudinal protein abundance changes occurring during hepatitis C virus (HCV)-associated liver disease progression in vivo. In this study, our goal was to identify molecular signatures, and potential key regulatory proteins, representative of the processes influencing early progression to fibrosis. We performed global protein profiling analyses on 24 liver biopsy specimens obtained from 15 HCV(+) liver transplant recipients at 6 and/or 12 months posttransplantation. Differentially regulated proteins associated with early progression to fibrosis were identified by analysis of the area under the receiver operating characteristic curve. Analysis of serum metabolites was performed on samples obtained from an independent cohort of 60 HCV(+) liver transplant patients. Computational modeling approaches were applied to identify potential key regulatory proteins of liver fibrogenesis. Among 4,324 proteins identified, 250 exhibited significant differential regulation in patients with rapidly progressive fibrosis. Patients with rapid fibrosis progression exhibited enrichment in differentially regulated proteins associated with various immune, hepatoprotective, and fibrogenic processes. The observed increase in proinflammatory activity and impairment in antioxidant defenses suggests that patients who develop significant liver injury experience elevated oxidative stresses. This was supported by an independent study demonstrating the altered abundance of oxidative stress-associated serum metabolites in patients who develop severe liver injury. Computational modeling approaches further highlight a potentially important link between HCV-associated oxidative stress and epigenetic regulatory mechanisms impacting on liver fibrogenesis. CONCLUSION: Our proteome and metabolome analyses provide new insights into the role for increased oxidative stress in the rapid fibrosis progression observed in HCV(+) liver transplant recipients. These findings may prove useful in prognostic applications for predicting early progression to fibrosis.
Authors: Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn Journal: Metabolism Date: 2010-04-27 Impact factor: 8.694
Authors: J Madill; B Arendt; E Aghdassi; C Chow; M Guindi; G Therapondos; L Lilly; J Allard Journal: Transplant Proc Date: 2010-06 Impact factor: 1.066
Authors: Michael L Washburn; Moses T Bility; Liguo Zhang; Grigoriy I Kovalev; Adam Buntzman; Jeffery A Frelinger; Walter Barry; Alexander Ploss; Charles M Rice; Lishan Su Journal: Gastroenterology Date: 2011-01-13 Impact factor: 22.682
Authors: Bobbie-Jo M Webb-Robertson; Lee Ann McCue; Katrina M Waters; Melissa M Matzke; Jon M Jacobs; Thomas O Metz; Susan M Varnum; Joel G Pounds Journal: J Proteome Res Date: 2010-10-08 Impact factor: 4.466
Authors: Stuart Thomson; Filippo Petti; Izabela Sujka-Kwok; Peter Mercado; James Bean; Melissa Monaghan; Sean L Seymour; Gretchen M Argast; David M Epstein; John D Haley Journal: Clin Exp Metastasis Date: 2010-12-31 Impact factor: 5.150
Authors: Magdalena Karolczak-Bayatti; Andrew D Loughney; Stephen C Robson; G Nicholas Europe-Finner Journal: J Cell Mol Med Date: 2011-01 Impact factor: 5.310
Authors: Kota Arima; Mai Chan Lau; Melissa Zhao; Koichiro Haruki; Jonathan A Nowak; Marios Giannakis; Charles S Fuchs; Shuji Ogino; Keisuke Kosumi; Kosuke Mima; Mancang Gu; Juha P Väyrynen; Tyler S Twombly; Yoshifumi Baba; Kenji Fujiyoshi; Junko Kishikawa; Chunguang Guo; Hideo Baba; William G Richards; Andrew T Chan; Reiko Nishihara; Jeffrey A Meyerhardt Journal: Mol Cancer Res Date: 2020-03-12 Impact factor: 5.852
Authors: Eric G Meissner; David Wu; Anu Osinusi; Dimitra Bon; Kimmo Virtaneva; Dan Sturdevant; Steve Porcella; Honghui Wang; Eva Herrmann; John McHutchison; Anthony F Suffredini; Michael Polis; Stephen Hewitt; Ludmila Prokunina-Olsson; Henry Masur; Anthony S Fauci; Shyamasundaran Kottilil Journal: J Clin Invest Date: 2014-07-01 Impact factor: 14.808
Authors: Caroline J Sands; Indra N Guha; Michael Kyriakides; Mark Wright; Olaf Beckonert; Elaine Holmes; William M Rosenberg; Muireann Coen Journal: Am J Gastroenterol Date: 2014-12-23 Impact factor: 10.864
Authors: Jason E McDermott; Deborah L Diamond; Courtney Corley; Angela L Rasmussen; Michael G Katze; Katrina M Waters Journal: BMC Syst Biol Date: 2012-04-30
Authors: Lauren E Ball; Bernice Agana; Susana Comte-Walters; Don C Rockey; Henry Masur; Shyam Kottilil; Eric G Meissner Journal: J Viral Hepat Date: 2021-08-19 Impact factor: 3.728
Authors: Alessia Virzì; Armando Andres Roca Suarez; Thomas F Baumert; Joachim Lupberger Journal: Cold Spring Harb Perspect Med Date: 2020-01-02 Impact factor: 5.159
Authors: Anannya Bhattacharya; Ahmed N Hegazy; Nikolaus Deigendesch; Lindsay Kosack; Jovana Cupovic; Richard K Kandasamy; Andrea Hildebrandt; Doron Merkler; Anja A Kühl; Bojan Vilagos; Christopher Schliehe; Isabel Panse; Kseniya Khamina; Hatoon Baazim; Isabelle Arnold; Lukas Flatz; Haifeng C Xu; Philipp A Lang; Alan Aderem; Akinori Takaoka; Giulio Superti-Furga; Jacques Colinge; Burkhard Ludewig; Max Löhning; Andreas Bergthaler Journal: Immunity Date: 2015-11-17 Impact factor: 31.745
Authors: Trina Das; Deborah L Diamond; Matthew Yeh; Sajida Hassan; Janine T Bryan; Jorge D Reyes; James D Perkins Journal: J Transplant Date: 2013-11-26